Glaukos Corp's next confirmed earnings release is scheduled for February 25, 2027.
| Earnings Date | 2/25/2027 |
As of September 30, 2026, Glaukos Corp has 59.17M shares outstanding.
| Shares Outstanding | 59.17M |
As of September 30, 2026, Glaukos Corp maintains a current ratio of 4.57, meaning it holds 4.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 14.22, indicating elevated leverage, while an interest coverage ratio of -26.96 demonstrates limited ability to service its debt obligations.
| Current Ratio | 4.57 |
| Quick Ratio | 3.84 |
| Debt / Equity | 14.22 |
| Debt / EBITDA | -0.79 |
| Interest Coverage | -26.96 |
Over the twelve months ended September 30, 2026, Glaukos Corp posted a negative return on equity (ROE) of -22.84, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -17.16, reflecting losses generated across the asset base. The company generates approximately 11.39M in revenue per employee across its workforce of 1,094.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.89 indicates how many times Glaukos Corp sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | -22.84 |
| Return on Assets (ROA) | -17.16 |
| Revenue Per Employee | 11.39M |
| Employee Count | 1,094.00 |
| Inventory Turnover | 3.89 |
Over the twelve months ended September 30, 2026, Glaukos Corp recorded an income tax benefit of -85.16M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -3.15B and -3.07B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.
| Income Tax | -85.16M |
Over the twelve months ended September 30, 2026, Glaukos Corp generated 12.47B in revenue and converted that into -3.07B in net income, yielding earnings per share of -52.07. EBITDA reached -2.35B, while operating income came in at -3.15B.
| Revenue | 12.47B |
| Gross Profit | 8.07B |
| Operating Income | -3.15B |
| Pretax Income | -3.15B |
| Net Income | -3.07B |
| EBITDA | -2.35B |
| EBIT | -3.18B |
| Earnings Per Share (EPS) | -52.07 |
As of September 30, 2026, Glaukos Corp holds 6.08B in cash and equivalents against 1.84B in total debt, resulting in a net debt position of -2.93B. Total book value stands at 12.95B, with working capital of 8.18B providing operational flexibility.
| Cash & Cash Equivalents | 6.08B |
| Total Debt | 1.84B |
| Net Debt | -2.93B |
| Equity (Book Value) | 12.95B |
| Book Value Per Share | 218.90 |
| Working Capital | 8.18B |
Glaukos Corp produced 861.50M in operating cash flow over the twelve months ended September 30, 2026. After subtracting -510.96M in capital expenditures, free cash flow totaled 350.54M - equivalent to 6.01 per share.
| Operating Cash Flow | 861.50M |
| Capital Expenditures | -510.96M |
| Free Cash Flow | 350.54M |
| FCF Per Share | 6.01 |
Over the twelve months ended September 30, 2026, Glaukos Corp posted a gross margin of 64.78, reflecting its pricing power and cost economics. The operating margin of -25.30 and net profit margin of -24.60 provide insight into operational efficiency.
| Gross Margin | 64.78 |
| Operating Margin | -25.30 |
| Pretax Margin | -25.28 |
| Profit Margin | -24.60 |
| EBITDA Margin | -18.81 |